ccdd_code,ccdd_formal_name,ccdd_type,policy_type,policy_reference,special_groupings_status,special_groupings_status_effective_time
"00050024","CODEINE PHOSPHATE SYRUP (codeine phosphate 25 mg per 5 mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00125083","DILAUDID (hydromorphone hydrochloride 2 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00125121","DILAUDID (hydromorphone hydrochloride 4 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00380571","LINCTUS CODEINE BLANC (codeine phosphate 10 mg per 5 mL oral solution) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00392472","SUPEUDOL 20 (oxycodone hydrochloride 20 mg suppository) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00392480","SUPEUDOL 10 (oxycodone hydrochloride 10 mg suppository) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00392561","MORPHINE SULFATE INJ 15MG/ML USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00392588","MORPHINE SULFATE INJ 10MG/ML USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00443948","SUPEUDOL 10 (oxycodone hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00497282","CODEINE PHOSPHATE INJ 30MG/ML (codeine phosphate 30 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00497290","CODEINE PHOSPHATE INJ 60MG/ML (codeine phosphate 60 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00507407","DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00544884","CODEINE PHOSPHATE INJECTION USP (codeine phosphate 30 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00591467","STATEX SYRUP 1MG/ML (morphine sulfate 1 mg per mL syrup) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00591475","STATEX SYRUP 5MG/ML (morphine sulfate 5 mg per mL syrup) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00593435","TEVA-CODEINE (codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00593451","TEVA-CODEINE (codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00594636","STATEX TABLET 25MG (morphine sulfate 25 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00594644","STATEX TAB 10MG (morphine sulfate 10 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00594652","STATEX TAB 5MG (morphine sulfate 5 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00596965","STATEX SUPPOSITORIES 20MG (morphine sulfate 20 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00607762","RATIO-MORPHINE (morphine hydrochloride 1 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00607770","RATIO-MORPHINE (morphine hydrochloride 5 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00608157","TEVA-OXYCODAN (acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00608165","TEVA-OXYCOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00614491","DOLORAL 1 (morphine hydrochloride 1 mg per mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00614505","DOLORAL 5 SIROP 5MG/ML (morphine hydrochloride 5 mg per mL syrup) LABORATOIRE ATLAS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00621935","STATEX DROPS 20MG/ML (morphine sulfate 20 mg per mL oral drops) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00632201","STATEX-SUPPOSITORIES 10MG (morphine sulfate 10 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00632228","STATEX SUPPOSITORIES 5MG (morphine sulfate 5 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00636908","MORPHINE SULFATE INJECTION USP (morphine sulfate 30 mg per 30 mL solution for injection vial) ICU MEDICAL CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00639389","STATEX SUPPOSITORIES 30MG (morphine sulfate 30 mg suppository) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00640409","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 10 mg per mL solution for injection 30 mL vial) ICU MEDICAL CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00647217","STATEX SYRUP 10MG/ML (morphine sulfate 10 mg per mL syrup) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00649619","MORPHINE SULFATE INJECTION USP (morphine sulfate 150 mg per 30 mL solution for injection vial) ICU MEDICAL CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00675962","STATEX TABLETS 50MG (morphine sulfate 50 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00690783","RATIO-MORPHINE (morphine hydrochloride 10 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00690791","RATIO-MORPHINE (morphine hydrochloride 20 mg per mL syrup) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00705438","DILAUDID (hydromorphone hydrochloride 1 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00705799","STATEX DPS 50MG/ML (morphine sulfate 50 mg per mL oral drops) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00725749","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00725757","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00725765","MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00786543","DILAUDID (hydromorphone hydrochloride 8 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00789739","SUPEUDOL 5 (oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00850314","MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00850322","MORPHINE SULFATE INJECTION USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00850330","MORPHINE SULFATE INJECTION USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00885401","PMS-HYDROMORPHONE TAB 4MG (hydromorphone hydrochloride 4 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00885428","PMS-HYDROMORPHONE TAB 8MG (hydromorphone hydrochloride 8 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00885436","PMS-HYDROMORPHONE TAB 2MG (hydromorphone hydrochloride 2 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"00885444","PMS-HYDROMORPHONE TAB 1MG (hydromorphone hydrochloride 1 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01901869","SANDOZ OPIUM & BELLADONNA (belladonna 15 mg and opium 65 mg suppository) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916386","PMS HYDROMORPHONE SIROP 1MG/ML (hydromorphone hydrochloride 1 mg per mL syrup) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916394","PMS HYDROMORPHONE SUPPOSITOIRE 3MG (hydromorphone hydrochloride 3 mg suppository) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916475","PERCOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916491","PERCOCET-DEMI (acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916548","ENDOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916580","HYCODAN SYRUP (hydrocodone bitartrate 5 mg per 5 mL syrup) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916599","HYCODAN TABLETS (hydrocodone bitartrate 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916963","TUSSIONEX (hydrocodone 5 mg and phenyltoloxamine 10 mg prolonged-release oral tablet) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01916971","TUSSIONEX (hydrocodone 5 mg per 5 mL and phenyltoloxamine 10 mg per 5 mL oral suspension) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01949047","MORPHINE-EPD (morphine sulfate 5 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01949055","MORPHINE-EPD (morphine sulfate 5 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"01964429","MORPHINE SULFATE INJ 5MG/ML USP (morphine sulfate 5 mg per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02009757","CODEINE 30 (codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02009889","CODEINE 15 (codeine phosphate 15 mg oral tablet) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014203","MS.IR (morphine sulfate 5 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014211","MS.IR (morphine sulfate 10 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014238","MS.IR (morphine sulfate 20 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014254","MS.IR (morphine sulfate 30 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014297","MS CONTIN SRT 30MG (morphine sulfate 30 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014300","MS CONTIN SRT 60MG (morphine sulfate 60 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014319","MS CONTIN SRT 100MG (morphine sulfate 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02014327","MS CONTIN SRT 200MG (morphine sulfate 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02015439","MS CONTIN SRT 15MG (morphine sulfate 15 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02019930","M-ESLON (morphine sulfate 10 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02019949","M-ESLON (morphine sulfate 30 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02019957","M-ESLON (morphine sulfate 60 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02019965","M-ESLON (morphine sulfate 100 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02021048","MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02021056","MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02049473","NOVAHISTINE DH (hydrocodone bitartrate 1.7 mg per 5 mL and phenylephrine hydrochloride 10 mg per 5 mL syrup) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02049481","NOVAHISTEX DH (hydrocodone bitartrate 5 mg per 5 mL and phenylephrine hydrochloride 20 mg per 5 mL syrup) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02125323","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02125331","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02125366","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02125382","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02125390","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02137240","MORPHINE SULPHATE INJECTION 2MG/ML (morphine sulfate 2 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02137267","MORPHINE SULPHATE INJECTION 50MG/ML (morphine sulfate 50 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02137984","TALWIN (pentazocine (pentazocine hydrochloride) 50 mg oral tablet) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02138018","DEMEROL (meperidine hydrochloride 50 mg oral tablet) SANOFI-AVENTIS CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02145901","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02163748","CODEINE CONTIN 100MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02163780","CODEINE CONTIN 150MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 150 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02163799","CODEINE CONTIN 200MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02177749","M-ESLON (morphine sulfate 15 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02177757","M-ESLON (morphine sulfate 200 mg prolonged-release oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02184435","KADIAN (morphine sulfate 20 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02184443","KADIAN (morphine sulfate 50 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02184451","KADIAN (morphine sulfate 100 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02224577","COPHYLAC (normethadone hydrochloride 10 mg per mL and p-hydroxyephedrine hydrochloride 20 mg per mL oral drops) BAUSCH HEALTH, CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02230302","CODEINE CONTIN 50MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 50 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02230769","DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02231934","OXY.IR (oxycodone hydrochloride 5 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02240131","OXY.IR (oxycodone hydrochloride 10 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02240132","OXY.IR (oxycodone hydrochloride 20 mg oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02241377","METADOL (methadone hydrochloride 10 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02241976","TALWIN (pentazocine (pentazocine lactate) 30 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242003","DEMEROL 50 MG/ML   (SINGLE USE, PRESERVATIVE FREE) (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242004","DEMEROL 75 MG/ML (meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242005","DEMEROL 100 MG/ML (meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242006","DEMEROL 100 MG/ML (meperidine hydrochloride 100 mg per mL solution for injection 20 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242163","KADIAN (morphine sulfate 10 mg prolonged-release oral capsule) BGP PHARMA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242468","RIVACOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) LABORATOIRE RIVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242484","MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02242504","BUTORPHANOL NASAL SPRAY (butorphanol tartrate 10 mg per mL nasal spray) AA PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02243562","HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02243978","PMS-CODEINE (codeine phosphate 15 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02243979","PMS-CODEINE (codeine phosphate 30 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02244080","DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02244290","METADOL-D (methadone hydrochloride 10 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02244508","PMS-BUTORPHANOL (butorphanol tartrate 10 mg per mL nasal spray) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02244790","SANDOZ MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02244791","SANDOZ MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02244792","SANDOZ MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02244797","HYDROMORPHONE HP FORTE INJECTION (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02245758","PMS-OXYCODONE - ACETAMINOPHEN (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02247374","METADOL-D (methadone hydrochloride 1 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02247694","METADOL (methadone hydrochloride 1 mg per mL oral solution) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02247698","METADOL (methadone hydrochloride 1 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02247699","METADOL (methadone hydrochloride 5 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02247700","METADOL (methadone hydrochloride 10 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02247701","METADOL (methadone hydrochloride 25 mg oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02262983","SUPEUDOL (oxycodone hydrochloride 20 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02264846","TRAMACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02268272","XYREM (sodium oxybate 500 mg per mL oral solution) JAZZ PHARMACEUTICALS IRELAND LIMITED","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"02275813","DURAGESIC (fentanyl 25 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02275821","DURAGESIC (fentanyl 50 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02275848","DURAGESIC (fentanyl 75 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02275856","DURAGESIC (fentanyl 100 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02282941","TEVA-FENTANYL (fentanyl 25 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02282968","TEVA-FENTANYL (fentanyl 50 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02282976","TEVA-FENTANYL (fentanyl 75 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02282984","TEVA-FENTANYL (fentanyl 100 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02286424","ZYTRAM XL (tramadol hydrochloride 150 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02286432","ZYTRAM XL (tramadol hydrochloride 200 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02286440","ZYTRAM XL (tramadol hydrochloride 300 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02286459","ZYTRAM XL (tramadol hydrochloride 400 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02295695","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02295709","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02296381","TRIDURAL (tramadol hydrochloride 100 mg prolonged-release oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02296403","TRIDURAL (tramadol hydrochloride 200 mg prolonged-release oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02296411","TRIDURAL (tramadol hydrochloride 300 mg prolonged-release oral tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02299194","RALIVIA (tramadol hydrochloride 100 mg prolonged-release oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02299208","RALIVIA (tramadol hydrochloride 200 mg prolonged-release oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02299216","RALIVIA (tramadol hydrochloride 300 mg prolonged-release oral tablet) VALEANT CANADA LP/VALEANT CANADA S.E.C.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02302764","TEVA-MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02302772","TEVA-MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02302780","TEVA-MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02302799","TEVA-MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02302802","TEVA-MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02306530","APO-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02307898","SANDOZ OXYCODONE/ACETAMINOPHEN (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02309882","PMS-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02309890","PMS-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02309904","PMS-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02309912","PMS-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02311925","TEVA-FENTANYL (fentanyl 12 mcg per hour transdermal patch) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02314630","APO-FENTANYL MATRIX (fentanyl 25 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02314649","APO-FENTANYL MATRIX (fentanyl 50 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02314657","APO-FENTANYL MATRIX (fentanyl 75 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02314665","APO-FENTANYL MATRIX (fentanyl 100 mcg per hour transdermal patch) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02319403","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02319411","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02319438","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02319446","TEVA-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02319977","PMS-OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02319985","PMS-OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02319993","PMS-OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02320398","M-EDIAT (morphine sulfate 5 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02320428","M-EDIAT (morphine sulfate 10 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02320436","M-EDIAT (morphine sulfate 20 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02320444","M-EDIAT (morphine sulfate 30 mg oral capsule) ETHYPHARM INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02324253","PDP-HYDROCODONE (hydrocodone bitartrate 5 mg per 5 mL syrup) PENDOPHARM DIVISION OF PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02324628","APO-OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02325950","OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02325969","OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02325977","OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02327112","SANDOZ FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02327120","SANDOZ FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02327139","SANDOZ FENTANYL PATCH (fentanyl 37 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02327147","SANDOZ FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02327155","SANDOZ FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02327163","SANDOZ FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02327171","OXYCODONE-ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02330105","RAN-FENTANYL MATRIX PATCH (fentanyl 12 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02330113","RAN-FENTANYL MATRIX PATCH (fentanyl 25 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02330121","RAN-FENTANYL MATRIX PATCH (fentanyl 50 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02330148","RAN-FENTANYL MATRIX PATCH (fentanyl 75 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02330156","RAN-FENTANYL MATRIX PATCH (fentanyl 100 mcg per hour transdermal patch) RANBAXY PHARMACEUTICALS CANADA INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02334186","DURAGESIC (fentanyl 12 mcg per hour transdermal patch) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02336790","APO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02337266","JURNISTA (hydromorphone hydrochloride 4 mg prolonged-release oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02337274","JURNISTA (hydromorphone hydrochloride 8 mg prolonged-release oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02337282","JURNISTA (hydromorphone hydrochloride 16 mg prolonged-release oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02337290","JURNISTA (hydromorphone hydrochloride 32 mg prolonged-release oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02339609","TARGIN (naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02339617","TARGIN (naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02339625","TARGIN (naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341174","BUTRANS 5 (buprenorphine 5 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341212","BUTRANS 10 (buprenorphine 10 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341220","BUTRANS 20 (buprenorphine 20 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341379","PMS-FENTANYL MTX (fentanyl 12 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341387","PMS-FENTANYL MTX (fentanyl 25 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341395","PMS-FENTANYL MTX (fentanyl 50 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341409","PMS-FENTANYL MTX (fentanyl 75 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02341417","PMS-FENTANYL MTX (fentanyl 100 mcg per hour transdermal patch) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02347180","TEVA-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02349469","ULTRAM (tramadol hydrochloride 50 mg oral tablet) JANSSEN INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02350815","MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02350890","MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02350912","MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02359502","HYDROMORPH CONTIN (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02359510","HYDROMORPH CONTIN (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02360322","ZYTRAM XL (tramadol hydrochloride 75 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02360349","ZYTRAM XL (tramadol hydrochloride 100 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02361361","OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364115","APO-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364123","APO-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364131","APO-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364158","APO-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364174","ABSTRAL (fentanyl (fentanyl citrate) 100 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364182","ABSTRAL (fentanyl (fentanyl citrate) 200 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364190","ABSTRAL (fentanyl (fentanyl citrate) 300 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364204","ABSTRAL (fentanyl (fentanyl citrate) 400 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364212","ABSTRAL (fentanyl (fentanyl citrate) 600 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02364220","ABSTRAL (fentanyl (fentanyl citrate) 800 mcg sublingual tablet) PALADIN LABS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02366746","APO-OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02366754","APO-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02366762","APO-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02366789","APO-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02372525","OXYNEO (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02372533","OXYNEO (oxycodone hydrochloride 15 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02372541","OXYNEO (oxycodone hydrochloride 30 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02372568","OXYNEO (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02372576","OXYNEO (oxycodone hydrochloride 60 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02372584","OXYNEO (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02372797","OXYNEO (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02373017","DURELA (tramadol hydrochloride 100 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02373025","DURELA (tramadol hydrochloride 200 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02373033","DURELA (tramadol hydrochloride 300 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02378272","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 50 mg oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02378280","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 75 mg oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02378299","NUCYNTA IR (tapentadol (tapentadol hydrochloride) 100 mg oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02383209","ACT TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) ACTAVIS PHARMA COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02386844","CO FENTANYL (fentanyl 12 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02386852","CO FENTANYL (fentanyl 25 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02386879","CO FENTANYL (fentanyl 50 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02386887","CO FENTANYL (fentanyl 75 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02386895","CO FENTANYL (fentanyl 100 mcg per hour transdermal patch) COBALT PHARMACEUTICALS COMPANY","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02387425","TARGIN (naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02388197","TARO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SUN PHARMA CANADA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02388308","JAMP-ACET-TRAMADOL (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) JAMP PHARMA CORPORATION","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02388324","MAR-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MARCAN PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02389800","MINT-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MINT PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02391554","PRIVA-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PHARMAPAR INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394170","ACT OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394189","ACT OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394197","ACT OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394200","ACT OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394219","ACT OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394596","METHADOSE (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394618","METHADOSE DYE FREE, SUGAR FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394766","APO-OXYCODONE CR (oxycodone hydrochloride 15 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394774","APO-OXYCODONE CR (oxycodone hydrochloride 30 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02394782","APO-OXYCODONE CR (oxycodone hydrochloride 60 mg prolonged-release oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02395657","FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02395665","FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02395673","FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02395681","FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02395703","FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02396696","MYLAN-FENTANYL MATRIX PATCH (fentanyl 12 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02396718","MYLAN-FENTANYL MATRIX PATCH (fentanyl 25 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02396726","MYLAN-FENTANYL MATRIX PATCH (fentanyl 50 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02396734","MYLAN-FENTANYL MATRIX PATCH (fentanyl 75 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02396742","MYLAN-FENTANYL MATRIX PATCH (fentanyl 100 mcg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02401657","PMS-TRAMADOL-ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02408007","FENTORA (fentanyl (fentanyl citrate) 100 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02408015","FENTORA (fentanyl (fentanyl citrate) 200 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02408023","FENTORA (fentanyl (fentanyl citrate) 400 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02408031","FENTORA (fentanyl (fentanyl citrate) 600 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02408058","FENTORA (fentanyl (fentanyl citrate) 800 mcg buccal tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02408090","MYLAN-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02408104","MYLAN-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) MYLAN PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02415577","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02415585","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02415593","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02415607","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02415615","NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet) ENDO VENTURES LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02417502","TRAMADOL-ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PRO DOC LIMITEE","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02424851","PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02424878","PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) PHARMASCIENCE INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02426153","APO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02426803","TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SANIS HEALTH INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02429969","TRAMADOL / ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02439050","AURO-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) AURO PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02450429","TARO-TRAMADOL ER (tramadol hydrochloride 100 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02450437","TARO-TRAMADOL ER (tramadol hydrochloride 200 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02450445","TARO-TRAMADOL ER (tramadol hydrochloride 300 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02450771","BUTRANS 15 (buprenorphine 15 mcg per hour transdermal patch) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02453908","ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02453916","ACT BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02460602","HYDROMORPHONE HYDROCHLORIDE INJECTION (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02465221","BELBUCA (buprenorphine (buprenorphine hydrochloride) 75 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02465248","BELBUCA (buprenorphine (buprenorphine hydrochloride) 150 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02465256","BELBUCA (buprenorphine (buprenorphine hydrochloride) 300 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02465264","BELBUCA (buprenorphine (buprenorphine hydrochloride) 450 mcg buccal film) PURDUE PHARMA","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02468085","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride dihydrate) 3 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02468093","SUBOXONE (buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride dihydrate) 4 mg sublingual tablet) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02468468","HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02469650","NRA-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) NORA PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02474921","PROBUPHINE (buprenorphine hydrochloride 80 mg implant) KNIGHT THERAPEUTICS INC.","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02474980","MORPHINE SULFATE INJECTION BP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476614","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476622","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476630","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476649","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476657","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476665","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476673","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02476681","APO-HYDROMORPHONE CR (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) APOTEX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02478889","SANDOZ MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02478897","SANDOZ MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02479672","AURO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) AURO PHARMA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02480859","MAR-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) MARCAN PHARMACEUTICALS INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02481979","SANDOZ METHADONE (methadone hydrochloride 10 mg per mL oral solution) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02482681","MORPHINE SULFATE INJECTION, USP (morphine sulfate 2 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02482746","MORPHINE SULFATE INJECTION, USP (morphine sulfate 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02483084","SUBLOCADE (buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02483092","SUBLOCADE (buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02485532","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag) STERINOVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"02485540","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag) STERINOVA INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700290","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700291","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700292","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700293","HYDROMORPHONE HP 10 (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700294","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700295","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700296","HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700297","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700298","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700299","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700300","HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700301","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700302","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700303","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700304","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700305","HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700340","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700341","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per mL solution for injection 20 mL vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700342","MORPHINE EXTRA-FORTE (morphine sulfate 50 mg per mL solution for injection 50 mL vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700343","MORPHINE FORTE (morphine sulfate 100 mg per 4 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700344","MORPHINE FORTE (morphine sulfate 25 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700345","MORPHINE HP 25 - 25MG/ML (morphine sulfate 100 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700346","MORPHINE HP 25 - 25MG/ML (morphine sulfate 25 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700347","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700348","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700349","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700350","MORPHINE HP 50 - 50MG/ML USP (morphine sulfate 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700351","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700352","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 1 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700353","MORPHINE SULFATE INJ 1MG/ML USP (morphine sulfate 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700354","MORPHINE SULFATE INJ 2MG/ML USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700355","MORPHINE SULFATE INJ 2MG/ML USP (morphine sulfate 2 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700356","MORPHINE SULFATE INJECTION SDZ (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700357","MORPHINE SULFATE INJECTION SDZ (morphine sulfate 50 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700358","MORPHINE SULPHATE INJECTION 1MG/ML (morphine sulfate 1 mg per mL solution for injection 50 mL vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700359","MORPHINE SULPHATE INJECTION 1MG/ML (morphine sulfate 5 mg per 5 mL solution for injection vial) HOSPIRA HEALTHCARE ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700447","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700448","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700449","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700450","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700451","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700486","FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700487","FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700488","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) TELIGENT OU","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700489","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) TELIGENT OU","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700516","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700517","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700518","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700519","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection ampoule) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700520","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700521","FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) PFIZER CANADA ULC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700957","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"77700958","HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) STERIMAX INC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000006","testosterone","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000010","methylphenidate","TM","500004","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000023","acetaminophen and caffeine and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000045","oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000045","oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000048","diazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000059","acetaminophen and oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000059","acetaminophen and oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000061","clonazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000065","acetaminophen and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000069","codeine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000069","codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000071","morphine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000071","morphine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000079","oxazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000087","temazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000088","alprazolam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000090","bromazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000091","flurazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000106","hydromorphone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000106","hydromorphone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000109","lorazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000127","fentanyl","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000127","fentanyl","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000162","dextroamphetamine","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000238","clobazam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000285","methadone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000285","methadone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000349","acetaminophen and tramadol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000369","tramadol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000372","buprenorphine and naloxone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000372","buprenorphine and naloxone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000387","lisdexamfetamine","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000774","acetylsalicylic acid and oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000774","acetylsalicylic acid and oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000775","buprenorphine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000775","buprenorphine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000776","butorphanol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000776","butorphanol","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000777","hydrocodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000777","hydrocodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000778","hydrocodone and phenyltoloxamine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000778","hydrocodone and phenyltoloxamine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000779","alcohol anhydrous and doxylamine and etafedrin and hydrocodone and sodium citrate","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000779","alcohol anhydrous and doxylamine and etafedrin and hydrocodone and sodium citrate","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000780","brompheniramine and guaifenesin and hydrocodone and phenylephrine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000780","brompheniramine and guaifenesin and hydrocodone and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000781","hydrocodone and phenylephrine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000781","hydrocodone and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000782","meperidine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000782","meperidine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000783","naloxone and oxycodone","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000783","naloxone and oxycodone","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000784","normethadone and p-hydroxyephedrine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000784","normethadone and p-hydroxyephedrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000785","belladonna and opium","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000785","belladonna and opium","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000786","pentazocine","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000786","pentazocine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000788","belladonna and ergotamine and phenobarbital","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000789","tapentadol","TM","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"8000789","tapentadol","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000799","phenobarbital","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000805","acetylsalicylic acid and butalbital and caffeine and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000806","acetylsalicylic acid and caffeine and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000808","acetylsalicylic acid and butalbital and caffeine","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000828","acetaminophen and codeine and doxylamine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000854","acetaminophen and chlorzoxazone and codeine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000859","acetaminophen and codeine and methocarbamol","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000861","acetylsalicylic acid and codeine and methocarbamol","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000925","brompheniramine and codeine and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8000926","brompheniramine and codeine and guaifenesin and phenylephrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001092","nitrazepam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001093","nabilone","TM","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001095","triazolam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001107","midazolam","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001121","zolpidem","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001350","chlordiazepoxide","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001351","chlordiazepoxide and clidinium","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001361","clorazepate","TM","500006","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001364","codeine and guaifenesin and pseudoephedrine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001403","nalbuphine","TM","500005","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001572","atropine and diphenoxylate","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001692","ammonium chloride and codeine and diphenhydramine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001900","codeine and guaifenesin and pheniramine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001920","remifentanil","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001940","sodium oxybate","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001940","sodium oxybate","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8001947","sufentanil","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8002028","ketamine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8002112","codeine and guaifenesin and pseudoephedrine and triprolidine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8002113","codeine and pseudoephedrine and triprolidine","TM","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"8002225","amphetamine mixed salts","TM","500003","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"9000001","meperidine hydrochloride 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000016","hydrocodone 5 mg and phenyltoloxamine 10 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000017","hydrocodone 5 mg per 5 mL and phenyltoloxamine 10 mg per 5 mL oral suspension","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000051","pentazocine (pentazocine hydrochloride) 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000069","oxycodone hydrochloride 10 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000070","oxycodone hydrochloride 20 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000094","acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000107","codeine phosphate 30 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000111","morphine sulfate 15 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000153","oxycodone hydrochloride 10 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000166","codeine phosphate 60 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000181","codeine phosphate 15 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000182","codeine phosphate 30 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000195","acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000201","hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000202","hydromorphone hydrochloride 2 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000203","hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000204","hydromorphone hydrochloride 4 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000206","hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000209","morphine hydrochloride 1 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000210","morphine sulfate 1 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000211","morphine sulfate 20 mg per mL oral drops","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000212","morphine sulfate 5 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000228","morphine hydrochloride 5 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000229","morphine sulfate 10 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000230","morphine sulfate 10 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000231","morphine sulfate 20 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000232","morphine sulfate 25 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000233","morphine sulfate 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000253","hydromorphone hydrochloride 1 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000258","morphine hydrochloride 10 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000259","morphine hydrochloride 20 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000260","morphine sulfate 150 mg per 30 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000262","morphine sulfate 30 mg per 30 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000263","morphine sulfate 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000264","morphine sulfate 50 mg per mL oral drops","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000280","morphine sulfate 10 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000299","morphine sulfate 10 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000319","fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000320","fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000321","fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000322","fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000323","fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000324","fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000328","hydromorphone hydrochloride 8 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000331","morphine sulfate 2 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000362","morphine sulfate 100 mg per 4 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000364","morphine sulfate 25 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000365","morphine sulfate 50 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000367","oxycodone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000375","belladonna 15 mg and opium 65 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000384","hydromorphone hydrochloride 1 mg per mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000385","hydromorphone hydrochloride 3 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000389","morphine sulfate 20 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000390","morphine sulfate 30 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000396","acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000432","morphine sulfate 5 mg per 10 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000433","morphine sulfate 5 mg per 5 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000474","morphine sulfate 100 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000475","morphine sulfate 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000476","morphine sulfate 10 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000477","morphine sulfate 15 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000478","morphine sulfate 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000479","morphine sulfate 30 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000480","morphine sulfate 30 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000481","morphine sulfate 60 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000482","morphine sulfate 60 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000566","codeine (codeine, codeine sulfate) 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000567","codeine (codeine, codeine sulfate) 150 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000568","codeine (codeine, codeine sulfate) 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000579","hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000582","hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000583","hydromorphone hydrochloride 3 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000584","hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000585","hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000586","hydromorphone hydrochloride 6 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000617","morphine sulfate 15 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000618","morphine sulfate 200 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000664","morphine sulfate 50 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000665","morphine sulfate 20 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000679","hydromorphone hydrochloride 12 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000680","hydromorphone hydrochloride 24 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000695","normethadone hydrochloride 10 mg per mL and p-hydroxyephedrine hydrochloride 20 mg per mL oral drops","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000709","codeine (codeine, codeine sulfate) 50 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000739","morphine sulfate 30 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000740","morphine sulfate 5 mg suppository","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000781","hydromorphone hydrochloride 30 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000884","fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000885","fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000890","oxycodone hydrochloride 20 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000913","butorphanol tartrate 10 mg per mL nasal spray","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000948","hydromorphone hydrochloride 18 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9000966","hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001034","methadone hydrochloride 1 mg per mL oral solution","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001041","methadone hydrochloride 10 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001042","methadone hydrochloride 1 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001043","methadone hydrochloride 25 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001044","methadone hydrochloride 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001121","acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001161","fentanyl 100 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001162","fentanyl 25 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001163","fentanyl 50 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001164","fentanyl 75 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001182","tramadol hydrochloride 150 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001183","tramadol hydrochloride 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001184","tramadol hydrochloride 300 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001185","tramadol hydrochloride 400 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001207","tramadol hydrochloride 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001226","buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001227","buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001249","fentanyl 12 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001304","hydromorphone hydrochloride 16 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001305","hydromorphone hydrochloride 32 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001306","hydromorphone hydrochloride 4 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001307","hydromorphone hydrochloride 8 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001315","buprenorphine 10 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001316","buprenorphine 20 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001317","buprenorphine 5 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001318","tramadol hydrochloride 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001322","naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001323","naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001324","naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001326","fentanyl 37 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001336","tramadol hydrochloride 75 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001340","hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001341","hydromorphone hydrochloride 9 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001344","fentanyl (fentanyl citrate) 100 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001345","fentanyl (fentanyl citrate) 200 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001346","fentanyl (fentanyl citrate) 300 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001347","fentanyl (fentanyl citrate) 400 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001349","fentanyl (fentanyl citrate) 800 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001352","fentanyl (fentanyl citrate) 600 mcg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001355","oxycodone hydrochloride 10 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001356","oxycodone hydrochloride 15 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001357","oxycodone hydrochloride 20 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001358","oxycodone hydrochloride 30 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001359","oxycodone hydrochloride 40 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001360","oxycodone hydrochloride 60 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001361","oxycodone hydrochloride 80 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001379","tramadol hydrochloride 100 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001380","tramadol hydrochloride 200 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001381","tramadol hydrochloride 300 mg prolonged-release oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001391","naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001392","morphine sulfate 50 mg per 5 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001393","oxycodone hydrochloride 5 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001395","methadone hydrochloride 10 mg per mL oral solution","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001424","fentanyl (fentanyl citrate) 100 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001425","fentanyl (fentanyl citrate) 200 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001426","fentanyl (fentanyl citrate) 400 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001427","fentanyl (fentanyl citrate) 600 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001428","fentanyl (fentanyl citrate) 800 mcg buccal tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001459","buprenorphine 15 mcg per hour transdermal patch","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001463","morphine sulfate 10 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001464","morphine sulfate 20 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001465","morphine sulfate 30 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001466","morphine sulfate 5 mg oral capsule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001473","hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9001474","hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9002679","hydrocodone bitartrate 1.7 mg per 5 mL and phenylephrine hydrochloride 10 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9002680","hydrocodone bitartrate 5 mg per 5 mL and phenylephrine hydrochloride 20 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9003646","brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9004321","sodium oxybate 500 mg per mL oral solution","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"9005007","tapentadol (tapentadol hydrochloride) 100 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9005008","tapentadol (tapentadol hydrochloride) 50 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9005009","tapentadol (tapentadol hydrochloride) 75 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9005492","tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9005493","tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9005494","tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9005495","tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9005496","tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006199","codeine phosphate 10 mg per 5 mL oral solution","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006201","alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrin hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006204","hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006207","codeine phosphate 25 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006208","meperidine hydrochloride 10 mg per mL solution for injection 30 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006211","morphine sulfate 250 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006212","morphine sulfate 500 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006213","morphine sulfate 50 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006214","morphine sulfate 50 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006219","morphine sulfate 50 mg per mL solution for injection 20 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006225","morphine sulfate 10 mg per 10 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006226","morphine sulfate 1 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006227","morphine sulfate 2 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006228","morphine sulfate 2 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006229","morphine sulfate 5 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006230","morphine sulfate 5 mg per mL solution for injection 30 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006243","hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006244","hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006245","hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006271","meperidine hydrochloride 100 mg per mL solution for injection 20 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006278","pentazocine (pentazocine lactate) 30 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006548","meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006625","meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9006626","meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9009882","hydrocodone bitartrate 5 mg oral tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9009884","hydrocodone bitartrate 5 mg per 5 mL syrup","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9012464","buprenorphine (buprenorphine hydrochloride) 150 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9012465","buprenorphine (buprenorphine hydrochloride) 300 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9012466","buprenorphine (buprenorphine hydrochloride) 450 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9012467","buprenorphine (buprenorphine hydrochloride) 75 mcg buccal film","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9012472","buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9012473","buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride) 4 mg sublingual tablet","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9012635","hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9013658","buprenorphine hydrochloride 80 mg implant","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9013672","codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL oral solution","NTP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Inactive","20170919"
"9014172","hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9014173","hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9014225","morphine sulfate 10 mg per 1 mL solution for injection vial","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9014238","buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
"9014239","buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe","NTP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Inactive","20170919"
